InspireMD, Inc. Overview
Pro stress-test →InspireMD is a medical device company focused on developing and commercializing products for treating carotid artery and other vascular diseases across Europe, Latin America, the Middle East, and Asia Pacific. The company's flagship product, CGuard Prime carotid stent system, received FDA approval and was commercially launched in the U.S. on July 9, 2025, marking a significant milestone in its evolution.
Strategic Profile
Pro stress-test →The company's MicroNet stent technology integrates a self-expandable nitinol stent with an innovative mesh structure designed to reduce embolic events during carotid interventions, enhancing both immediate and long-term patient outcomes. InspireMD's business model revolves around direct sales of innovative stent systems, and the company has streamlined manufacturing and enhanced operational capabilities in strategic regions, with its new U.S. headquarters established to strengthen commercial infrastructure.
Competitive Landscape
Pro stress-test →InspireMD distinguishes itself through specialized focus on carotid stenting systems, cultivating a niche by addressing unmet needs in carotid artery disease management through state-of-the-art technology with clinical validation. Primary competitors in carotid stent market include Abbott Vascular, Boston Scientific, and Medtronic, though InspireMD's MicroNet embolic protection technology offers differentiated positioning.
Industry Context
InspireMD, Inc. operates in Medical Devices - Cardiovascular Intervention & Stroke Prevention.
Key facts
Headquarters: Miami, Florida, USA · Revenue: $7.0M · Market cap: $88.6M